| scholarly article | Q13442814 |
| P2093 | author name string | Dow SW | |
| Potter TA | |||
| Heath TD | |||
| Elmslie RE | |||
| Willson AP | |||
| Fradkin LG | |||
| Liggitt DH | |||
| P433 | issue | 18 | |
| P304 | page(s) | 2961-2972 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases | |
| P478 | volume | 10 |
| Q40410230 | Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer |
| Q36562646 | Alleviation of lung inflammatory responses by adeno-associated virus 2/9 vector carrying CC10 in OVA-sensitized mice |
| Q45886686 | Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis |
| Q45887356 | Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy |
| Q44078795 | Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity |
| Q90928865 | Biomaterial-assisted targeted modulation of immune cells in cancer treatment |
| Q34313548 | Cationic lipid-mediated transfection in vitro and in vivo (review). |
| Q35627914 | Delivery systems for pulmonary gene therapy |
| Q85171736 | Development of Tissue Pressure-mediated Transfection Method Aimed at Organ-specific Gene Expression Control |
| Q40608057 | Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid]. |
| Q27486380 | Efficacy of cationic lipid–DNA complexes (CLDC) on hepatitis B virus in transgenic mice |
| Q43087994 | Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice |
| Q37851520 | Evaluating the role of IL-12 based therapies in ovarian cancer: a review of the literature |
| Q28648083 | Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent |
| Q38363923 | Immunotherapy for canine cancer--is it time to go back to the future? |
| Q35012639 | In vivo characteristics of cationic liposomes as delivery vectors for gene therapy |
| Q35819354 | Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection |
| Q81152786 | Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma |
| Q36517160 | Liposome-nucleic acid immunotherapeutics |
| Q41679793 | Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma |
| Q35600772 | Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma. |
| Q36314788 | Long-circulating polymeric nanovectors for tumor-selective gene delivery |
| Q45912169 | Modulation of peripheral immune responses by paclitaxel-ifosfamide-cisplatin chemotherapy in advanced non-small-cell lung cancer. |
| Q37145069 | Protection from pneumonic infection with burkholderia species by inhalational immunotherapy |
| Q78840100 | The double-edged cytokine sword of non-viral gene targeting to tumors |
| Q40639529 | Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model |
| Q44345846 | Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes |
| Q81838768 | Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes |
| Q40255867 | Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity |
Search more.